Exicure Inc
NASDAQ:XCUR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Exicure Inc
NASDAQ:XCUR
|
US |
|
P
|
Pegasystems Inc
F:PEA
|
US |
|
C
|
Choice Hotels International Inc
F:CZH
|
US |
|
GomSpace Group AB
F:1G2
|
SE |
|
O
|
O'Reilly Automotive Inc
DUS:OM6
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Exicure Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Exicure Does
Exicure is a biotechnology company that develops experimental medicines based on spherical nucleic acid, or SNA, technology. Its core work is to design and test drug candidates that aim to turn genes on or off more precisely than traditional medicines, with the goal of treating serious diseases.
- Headquarters
- United States of America US
- Employees
- 8
- IPO date
- May 9, 2018